Featured Research

from universities, journals, and other organizations

Lactating tsetse flies models for lactating mammals?

Date:
April 18, 2012
Source:
Society for the Study of Reproduction
Summary:
An unprecedented study of intra-uterine lactation in the tsetse fly reveals that an enzyme found in the fly's milk functions similarly in mammals, making the tsetse a potential model for lipid metabolism during mammalian lactation. Better yet, reduced levels of this enzyme led to poor health in offspring, leading the authors to suggest that targeting it could help decrease the tsetse population in Africa and so reduce the incidence of sleeping sickness.

There have been a large number of studies about SMase and associated enzymes in mammals, but almost none in insects. This image shows immunolocalization of SMase in the tsetse fly reproductive tract during pregnancy.
Credit: Image modified from Benoit et al., Biol Reprod 2012

An unprecedented study of intra-uterine lactation in the tsetse fly, just published in Biology of Reproduction's "Papers-in-Press," reveals that an enzyme found in the fly's milk functions similarly in mammals, making the tsetse a potential model for lipid metabolism during mammalian lactation.

Better yet, reduced levels of this enzyme led to poor health in offspring, leading the authors to suggest that targeting it could help decrease the tsetse population in Africa and so reduce the incidence of sleeping sickness. Tsetse flies are bloodsucking flies that inhabit much of subsaharan Africa. They are similar in size to a horsefly and breed along rivers and streams. A pathogenic species of parasite in the genus Trypanosoma can be taken in by the fly while taking a blood meal from an infected human or animal. Flies carrying the parasite can then transmit it to other humans or animals. The disease caused by the trypanosomes is known as sleeping sickness in humans and nagana in wild and domestic animals, including pigs, cattle, and horses.

Sleeping sickness affects about 37 countries and 60 million people, and an estimated 50,000 to 70,000 individuals are infected. Efforts to combat the disease are varied. One effective technique involves sterilizing male tsetse flies and then releasing them to compete with the wild males for breeding rights. The authors of this study suggest that manipulating production of the SMase enzyme and other essential milk proteins in female flies could also aid population reduction efforts.

This is the first study to uncover the biochemical mechanisms of lactation in tsetse flies. Yale University's Joshua B. Benoit and colleagues, with the help of researchers from the Slovak Academy of Sciences, documented that a sphingomyelinase (SMase) enzyme is present in tsetse milk during lactation.

This enzyme is essential for the production of a key component of cell membranes and it functions similarly during mammalian lactation.

Unlike most flies, the female tsetse produces a single egg and ovulates the egg into a uterus. When the larva hatches, it remains in the uterus until it has completed larval development. While the larva is in the uterus, the female fly expresses SMase as a component of the milk secretion of the fly's milk glands. The larva feeds on the milk, and acidic conditions in the larval gut activate the enzyme. When the researchers reduced SMase levels in the lactating mother, the offspring's development and health were impaired.

In humans, defects in SMase-encoding genes causes Niemann-Pick Disease, a neurodegenerative disorder that, in severe cases, causes death before three years of age. Although the mammalian and insect SMases differ, the basic structure and function of the enzymes and their products are similar. Thus, insects could serve as model systems for studying metabolic diseases related to SMase deficiency.


Story Source:

The above story is based on materials provided by Society for the Study of Reproduction. Note: Materials may be edited for content and length.


Journal Reference:

  1. Benoit JB, Attardo GM, Michalkova V, Takac P, Bohova J, Aksoy S. Sphingomyelinase activity in mother's milk is essential for juvenile development: a case from lactating tsetse flies. Biology of Reproduction, 2012; (in press) DOI: 10.1095/biolreprod.112.100008

Cite This Page:

Society for the Study of Reproduction. "Lactating tsetse flies models for lactating mammals?." ScienceDaily. ScienceDaily, 18 April 2012. <www.sciencedaily.com/releases/2012/04/120418162302.htm>.
Society for the Study of Reproduction. (2012, April 18). Lactating tsetse flies models for lactating mammals?. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/04/120418162302.htm
Society for the Study of Reproduction. "Lactating tsetse flies models for lactating mammals?." ScienceDaily. www.sciencedaily.com/releases/2012/04/120418162302.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins